Other papers submitted by: Dr Veli-Pekka Harjola

open access to scientific and medical research

News:

Expressions of interest for Editor-in-Chief - the International Medical Case Reports Journal Read more

Back to User profile » Dr Veli-Pekka Harjola

Paper published by Dr Veli-Pekka Harjola:

Original Research

Highly-accessed

Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland

Hallinen T, Kivelä S, Soini E, Harjola VP, Pesonen M

ClinicoEconomics and Outcomes Research 2023, 15:1-13

Published Date: 6 January 2023